ArticleTargeted oncology2018
Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.
Maria Alsina et al.PubMed ↗Publisher ↗
No numbers read from the abstract.